Séverine Guiu
Inserm(FR)Université de Montpellier(FR)Centre Hospitalier Universitaire de Montpellier(FR)Institut de Recherche en Cancérologie de Montpellier(FR)Institut Regional du Cancer de Montpellier(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, PARP inhibition in cancer therapy
Most-Cited Works
- → Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis(2016)399 cited
- → Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement(2012)291 cited
- → Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer(2009)256 cited
- → Visceral Fat Area as a New Independent Predictive Factor of Survival in Patients with Metastatic Renal Cell Carcinoma Treated with Antiangiogenic Agents(2011)171 cited
- → Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review(2020)142 cited
- → Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact